LIFESTREAM PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LIFESTREAM PHARMA
Largest movements
- Cash +€230,610
up €230,610 (+65.6%), from €351,309 to €581,918
mainly Depreciation (+€178,868) and Trade debts (+€144,430)
- Intangible fixed assets -€178,347
down €178,347 (-35.0%), from €509,592 to €331,245
- Tangible fixed assets -€85,438
down €85,438 (-98.0%), from €87,145 to €1,707
of which Plant, machinery and equipment: -€84,917
- Stocks and contracts +€25,976
up €25,976 (+67.1%), from €38,716 to €64,692
- Trade debts +€144,430
up €144,430 (+161%), from €89,835 to €234,264
- Profit (loss) carried forward -€99,084
down €99,084 (-15.1%), from -€658,083 to -€757,166
- Debts after one year -€57,410
no longer reported in 2025 (was €57,410)
- Current portion of long-term debt -€29,702
down €29,702 (-47.3%), from €62,806 to €33,104
- Short-term financial debts +€27,527
new in 2025: €27,527
- Gross operating margin -€77,304
down €77,304 (-31.7%), from €243,992 to €166,688
- Other operating charges +€52,470
up €52,470 (+5,423%), from €968 to €53,438
- Depreciation -€14,206
down €14,206 (-7.4%), from €193,074 to €178,868
- Financial charges -€8,511
down €8,511 (-53.5%), from €15,903 to €7,391
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,387,963 | €1,376,613 | -€11,351 | -0.8% |
| Fixed assets | 21/28 | €596,873 | €333,088 | -€263,785 | -44.2% |
| Intangible fixed assets | 21 | €509,592 | €331,245 | -€178,347 | -35.0% |
| Tangible fixed assets | 22/27 | €87,145 | €1,707 | -€85,438 | -98.0% |
| Plant, machinery and equipment | 23 | €84,917 | - | -€84,917 | |
| Furniture and vehicles | 24 | €2,228 | €1,707 | -€521 | -23.4% |
| Financial fixed assets | 28 | €137 | €137 | = | 0.0% |
| Current assets | 29/58 | €791,090 | €1,043,524 | +€252,434 | +31.9% |
| Stocks and contracts in progress | 3 | €38,716 | €64,692 | +€25,976 | +67.1% |
| Stocks | 30/36 | €38,716 | €64,692 | +€25,976 | +67.1% |
| Amounts receivable within one year | 40/41 | €400,774 | €391,239 | -€9,534 | -2.4% |
| Trade receivables | 40 | €359,271 | €380,461 | +€21,190 | +5.9% |
| Other amounts receivable | 41 | €41,503 | €10,778 | -€30,725 | -74.0% |
| Cash at bank and in hand | 54/58 | €351,309 | €581,918 | +€230,610 | +65.6% |
| Deferred charges and accrued income | 490/1 | €291 | €5,674 | +€5,383 | +1,850% |
| Total equity and liabilities | 10/49 | €1,387,963 | €1,376,613 | -€11,351 | -0.8% |
| Equity | 10/15 | €1,177,913 | €1,078,829 | -€99,084 | -8.4% |
| Contributions | 10/11 | €1,835,995 | €1,835,995 | = | 0.0% |
| Capital | 10 | €1,835,995 | €1,835,995 | = | 0.0% |
| Issued capital | 100 | €1,835,995 | €1,835,995 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€658,083 | -€757,166 | -€99,084 | -15.1% |
| Amounts payable | 17/49 | €210,050 | €297,784 | +€87,733 | +41.8% |
| Amounts payable after more than one year | 17 | €57,410 | - | -€57,410 | |
| Financial debts | 170/4 | €57,410 | - | -€57,410 | |
| Amounts payable within one year | 42/48 | €152,640 | €294,895 | +€142,255 | +93.2% |
| Current portion of amounts payable after more than one year | 42 | €62,806 | €33,104 | -€29,702 | -47.3% |
| Financial debts | 43 | - | €27,527 | +€27,527 | |
| Other loans | 439 | - | €27,527 | +€27,527 | |
| Trade debts | 44 | €89,835 | €234,264 | +€144,430 | +161% |
| Suppliers | 440/4 | €89,835 | €234,264 | +€144,430 | +161% |
| Accrued charges and deferred income | 492/3 | - | €2,888 | +€2,888 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €193,074 | €178,868 | -€14,206 | -7.4% |
| Other operating charges | 640/8 | €968 | €53,438 | +€52,470 | +5,423% |
| Non-recurring operating charges | 66A | - | €26,343 | +€26,343 | |
| Gross operating margin | 9900 | €243,992 | €166,688 | -€77,304 | -31.7% |
| Operating profit (loss) | 9901 | €49,950 | -€91,962 | -€141,911 | |
| Financial income | 75/76B | €286 | €269 | -€17 | -5.9% |
| Recurring financial income | 75 | €286 | €269 | -€17 | -5.9% |
| Financial charges | 65/66B | €15,903 | €7,391 | -€8,511 | -53.5% |
| Recurring financial charges | 65 | €15,903 | €7,391 | -€8,511 | -53.5% |
| Profit (loss) for the period before taxes | 9903 | €34,333 | -€99,084 | -€133,417 | |
| Profit (loss) for the period | 9904 | €34,333 | -€99,084 | -€133,417 | |
| Profit (loss) for the period to be appropriated | 9905 | €34,333 | -€99,084 | -€133,417 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.